Cargando…

N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non–Small Cell Lung Cancer Prognosis

Aberrant N6-methyladenosine (m6A) RNA methylation regulatory genes and related gene alternative splicing (AS) could be used to predict the prognosis of non–small cell lung carcinoma. This study focused on 13 m6A regulatory genes (METTL3, METTL14, WTAP, KIAA1429, RBM15, ZC3H13, YTHDC1, YTHDC2, YTHDF1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Zhenyu, Cai, Qidong, Zhang, Pengfei, He, Boxue, Peng, Xiong, Tu, Guangxu, Peng, Weilin, Wang, Li, Yu, Fenglei, Wang, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226009/ https://www.ncbi.nlm.nih.gov/pubmed/34179079 http://dx.doi.org/10.3389/fmolb.2021.657087

Ejemplares similares

Switched alternative splicing events as attractive features in lung squamous cell carcinoma
por: He, Boxue, et al.
Publicado: (2022)

Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods
por: Cai, Qidong, et al.
Publicado: (2020)

Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma
por: Tu, Guangxu, et al.
Publicado: (2021)

A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma
por: Tu, Guangxu, et al.
Publicado: (2021)

DNA methylome and transcriptome analysis established a model of four differentially methylated positions (DMPs) as a diagnostic marker in esophageal adenocarcinoma early detection
por: Peng, Weilin, et al.
Publicado: (2021)

Decreased IL-6 and NK Cells in Early-Stage Lung Adenocarcinoma Presenting as Ground-Glass Opacity
por: Zhang, Pengfei, et al.
Publicado: (2021)

A Machine-Learning Approach to Developing a Predictive Signature Based on Transcriptome Profiling of Ground-Glass Opacities for Accurate Classification and Exploring the Immune Microenvironment of Early-Stage LUAD
por: Zhao, Zhenyu, et al.
Publicado: (2022)

Alternative Splicing in Neurogenesis and Brain Development
por: Su, Chun-Hao, et al.
Publicado: (2018)

Editorial: Alternative Splicing in Health and Disease
por: Kahraman, Abdullah, et al.
Publicado: (2022)

Overexpression of LINC00551 promotes autophagy-dependent ferroptosis of lung adenocarcinoma via upregulating DDIT4 by sponging miR-4328
por: Peng, Xiong, et al.
Publicado: (2022)

New Insights on the Role of N(6)-Methyladenosine RNA Methylation in the Physiology and Pathology of the Nervous System
por: Dermentzaki, Georgia, et al.
Publicado: (2020)

Metagenomic analysis of the microbiome of lung adenocarcinoma with pure ground‐glass opacity
por: Zhao, Zhenyu, et al.
Publicado: (2022)

The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer
por: El Marabti, Ettaib, et al.
Publicado: (2018)

Alternative Splicing Regulator RBM20 and Cardiomyopathy
por: Watanabe, Takeshi, et al.
Publicado: (2018)

Validated Impacts of N6-Methyladenosine Methylated mRNAs on Apoptosis and Angiogenesis in Myocardial Infarction Based on MeRIP-Seq Analysis
por: Zhang, Yingjie, et al.
Publicado: (2022)

Efficient Detection of the Alternative Spliced Human Proteome Using Translatome Sequencing
por: Wu, Chun, et al.
Publicado: (2022)

Whole-genome DNA methylation and DNA methylation-based biomarkers in lung squamous cell carcinoma
por: Cai, Qidong, et al.
Publicado: (2023)

Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method
por: Cai, Qidong, et al.
Publicado: (2020)

Alteration of N6-Methyladenosine RNA Profiles in Cisplatin-Induced Acute Kidney Injury in Mice
por: Li, Can-Ming, et al.
Publicado: (2021)

N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma
por: Zhao, Zhiying, et al.
Publicado: (2022)

N(6)-Methyladenosine, DNA Repair, and Genome Stability
por: Qu, Fei, et al.
Publicado: (2021)

Systematic Analyses of the Role of the Reader Protein of N(6)-Methyladenosine RNA Methylation, YTH Domain Family 2, in Liver Hepatocellular Carcinoma
por: Shao, Xiang-yang, et al.
Publicado: (2020)

Alternative Splicing of MXD3 and Its Regulation of MXD3 Levels in Glioblastoma
por: Ngo, Tin, et al.
Publicado: (2019)

Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma
por: Bian, Saiyan, et al.
Publicado: (2020)

Comprehensive Analysis of HDAC Family Identifies HDAC1 as a Prognostic and Immune Infiltration Indicator and HDAC1-Related Signature for Prognosis in Glioma
por: Fan, Yuxiang, et al.
Publicado: (2021)

Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
por: Shi, Yuanxin, et al.
Publicado: (2023)

Position Specific Alternative Splicing and Gene Expression Profiles Along the Tonotopic Axis of Chick Cochlea
por: Koo, Heiyeun, et al.
Publicado: (2021)

A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

A Metabolism-Related Radiomics Signature for Predicting the Prognosis of Colorectal Cancer
por: Cai, Du, et al.
Publicado: (2021)

HMGA1a Induces Alternative Splicing of the Estrogen Receptor-αlpha Gene by Trapping U1 snRNP to an Upstream Pseudo-5′ Splice Site
por: Ohe, Kenji, et al.
Publicado: (2018)

The Pyroptosis-Related Gene Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Shuqiao, et al.
Publicado: (2022)

Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma
por: Luo, Yiming, et al.
Publicado: (2021)

A Metabolic Gene Signature to Predict Breast Cancer Prognosis
por: Lu, Jun, et al.
Publicado: (2022)

A novel pyroptosis-regulated gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2022)

Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer
por: Jiang, Minxiao, et al.
Publicado: (2021)

Identification and Development of a Novel 4-Gene Immune-Related Signature to Predict Osteosarcoma Prognosis
por: Cao, Mingde, et al.
Publicado: (2020)

Development of an Aging-Related Gene Signature for Predicting Prognosis, Immunotherapy, and Chemotherapy Benefits in Rectal Cancer
por: Wang, Yangyang, et al.
Publicado: (2022)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

A metabolism-associated gene signature for prognosis prediction of hepatocellular carcinoma
por: Tian, Yilin, et al.
Publicado: (2022)

Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity
por: Xiong, Zhizhong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7lujrsiorc7eeficjcaq5sfgo6